DelMar Pharmaceuticals’ Acquisition of Adgero Biopharmaceuticals

Ambrogio Visconti

Lowenstein Sandler LLP represented DelMar Pharmaceuticals in the transaction. DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) and Adgero Biopharmaceuticals Holdings, Inc. have entered into a definitive merger agreement…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Ambrogio Visconti

…

This content is for Standard 1 Year members only.
Login Join Now